<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03695588</url>
  </required_header>
  <id_info>
    <org_study_id>CWIUH-QLB</org_study_id>
    <nct_id>NCT03695588</nct_id>
  </id_info>
  <brief_title>Quadratus Lumborum Block (QLB) for Pain Relief After Caesarean Section</brief_title>
  <official_title>Quadratus Lumborum Block (QLB) for Pain Relief After Caesarean Section: A Prospective, Double-blind, Randomised Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Coombe Women and Infants University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Coombe Women and Infants University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is currently a gap in the literature with regards to the utility of the QLB performed
      in conjunction with intrathecal morphine (ITM) for Caesarean section. The aim of the study is
      to assess the efficacy of the QLB as part of a multi-modal analgesic approach in patients
      after caesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post-operative pain relief management remains challenging after Caesarean-section. The
      perfect postoperative analgesic regimen is yet to be elucidated, but opioids remain a
      cornerstone whether they are administered intra-thecally, or systemically or both.
      Unfortunately, opioids are associated with significant adverse effects such as respiratory
      depression, post-operative nausea and vomiting (PONV), sedation and pruritus. Therefore, the
      search for opioid sparing analgesic techniques is important.

      The study treatment consists of a quadratus lumborum block (QLB) of either 0.25%
      Levobupivacaine or a simulated sham QLB after C-section under spinal anaesthesia. The
      participants will be randomized into one of two groups with an internet based randomisation
      tool, and then allocated to either group as per the allocation in a sealed opaque envelope.

      Spinal anaesthesia will be performed in a standardised manner using 10-15mg hyperbaric
      bupivacaine, 20ug fentanyl and 100ug preservative free morphine. Anaesthetic and surgical
      management will be conducted as per the usual manner. Diclofenac 100mg suppositories and IV
      Paracetamol 1g will be administered at the end of surgery. A Morphine PCA will be connected
      to the patient in the recovery room after the intervention.

      The bilateral posterior QLB will be performed after surgery in the supine position in an
      aseptic manner. The patient will be blinded to the group intervention as the sterile drapes
      will be left hanging blocking the patient's view of the procedure. The block from the spinal
      anaesthetic will mean the patient is unaware of the procedure being carried out. A
      curvilinear ultrasound probe will be used to identify the quadratus lumborum muscle.

      Intervention group:

      Aseptic, ultrasound guided, bilateral QLB using a posterior approach. This is known as the
      QLB 2 approach. A maximum volume of 20 ml of 0.25% Levobupivacaine will be administered each
      side. After the procedure a sterile dressing will be placed on the puncture site.

      Placebo group:

      The patient will be sterilized, draped and scanned in the same manner as the intervention
      group, until the target injection point is identified. The operator will use a blunt needle
      to apply pressure to the skin, (without breaking the skin), for one minute as if they are
      performing the procedure. This will be performed bilaterally. After the procedure, a sterile
      dressing will be placed over the pressure area.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 30, 2018</start_date>
  <completion_date type="Actual">April 24, 2019</completion_date>
  <primary_completion_date type="Actual">April 24, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>IV PCA Morphine consumption up to 24 hours.</measure>
    <time_frame>24 hours</time_frame>
    <description>Intravenous PCA (patient controlled analgesia) morphine consumption up to 24 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain scores at rest.</measure>
    <time_frame>6, 12, 24, 48 hours</time_frame>
    <description>VAS (visual analogue scale) pain scores at rest - lying supine in bed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores on movement.</measure>
    <time_frame>6, 12, 24, 48 hours</time_frame>
    <description>VAS pain scores on movement - raising head and shoulders off pillow when lying supine in bed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting.</measure>
    <time_frame>24, 48 hours</time_frame>
    <description>The incidence of N+V requiring rescue anti-emetics.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IV PCA morphine bolus demands.</measure>
    <time_frame>24 hours</time_frame>
    <description>Intravenous PCA (patient controlled analgesia) morphine bolus demands up to 24 hours.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid consumption at 48 hours.</measure>
    <time_frame>48 hours</time_frame>
    <description>Total opioid consumption at 48 hours - converted to IV morphine equivalents.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QbsQoR-11.</measure>
    <time_frame>24, 48 hours</time_frame>
    <description>Quality of Recovery questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QoR-15.</measure>
    <time_frame>24, 48 hours</time_frame>
    <description>Quality of Recovery questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Quadratus Lumborum Block</condition>
  <arm_group>
    <arm_group_label>Quadratus lumborum block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bilateral posterior QLB with 20ml 0.25% L-Bupivacaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham QLB</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham QLB - Ultrasound identification of QLB followed by skin pressure with blunt needle. Patient blinded due to residual spinal anaesthetic block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Quadratus lumborum block</intervention_name>
    <description>Ultrasound guided Quadratus Lumborum block using a posterior approach. (QLB 2)</description>
    <arm_group_label>Quadratus lumborum block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham QLB</intervention_name>
    <description>Sham QLB - Ultrasound identification of QLB followed by skin pressure with blunt needle.</description>
    <arm_group_label>Sham QLB</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Elective Caesarean section under spinal anaesthesia.

          -  Age &gt; 18 years old.

          -  Singleton pregnancy.

        Exclusion Criteria:

          -  Contraindication to spinal or regional anaesthesia.

          -  Allergy/sensitivity/contraindication to study medications.

          -  Unable to comprehend visual analogue scale.

          -  BMI &gt; 40.

          -  Booking weight &lt;40kg.

          -  History of chronic pain or regular opioid use.

          -  Pre-eclampsia.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Terry Tan</last_name>
    <role>Principal Investigator</role>
    <affiliation>Head of Department of Anaesthesia CWIUH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Coombe Women and Infants University Hospital</name>
      <address>
        <city>Dublin</city>
        <zip>00000</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>October 1, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 4, 2018</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Coombe Women and Infants University Hospital</investigator_affiliation>
    <investigator_full_name>Ruairi Irwin</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>pain relief</keyword>
  <keyword>Caesarean</keyword>
  <keyword>Cesarean</keyword>
  <keyword>c-section</keyword>
  <keyword>intrathecal morphine</keyword>
  <keyword>analgesia</keyword>
  <keyword>QLB</keyword>
  <keyword>QL</keyword>
  <keyword>QLB2</keyword>
  <keyword>QL2</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

